Why Axsome Therapeutics, Inc. (AXSM) stock moved
Axsome Therapeutics, Inc. (AXSM) shares rose 3.8% to $220.89 as of August 11, 2026, a moderate gain from the prior close of $212.74. BestStocks flagged the session as a major change for AXSM. The move is tied to an earnings miss. Below, we break down what changed for AXSM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Earnings Miss
AXSM rose 3.8% in its latest session, moving from $212.74 to $220.89.
What it means for Axsome Therapeutics, Inc. investors
For Axsome Therapeutics, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive 3.8% session move; Axsome Therapeutics, Inc. (AXSM) moved +6.91% from $221.64 to $236.95 on 2026-07-21. Weighing against that: Earnings missed expectations; Axsome Therapeutics, Inc. (AXSM) moved -2.97% from $237.04 to $230.00 on 2026-07-17. Wall Street's consensus price target sits at $269.35, implying +21.9% upside from $220.89. BestStocks rates the overall signal quality medium (73/100).
AXSM price reaction
AXSM last traded at $220.89, up $8.15 (+3.83%) from the previous close of $212.74. The session traded on 1.7× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $210.13 and $241.53, and it currently sits about 34% of the way up that band.
Bullish and bearish analyst opinions on Axsome Therapeutics, Inc. (AXSM)
The consensus analyst price target on Axsome Therapeutics, Inc. (AXSM) is $269.35, 21.9% above the recent $220.89. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 0 downgrades. Here is how the bullish and bearish cases on AXSM line up.
The bullish case
- Wall Street's consensus price target of $269.35 implies +21.9% upside from $220.89.
- The Street's most bullish target is $380.00 (+72.0%).
- Positive 3.8% session move.
- Axsome Therapeutics, Inc. (AXSM) moved +6.91% from $221.64 to $236.95 on 2026-07-21.
The bearish case
- The most bearish analyst target is $200.00 (-9.5%).
- Earnings missed expectations.
- Axsome Therapeutics, Inc. (AXSM) moved -2.97% from $237.04 to $230.00 on 2026-07-17.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 11, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for AXSM
In-depth AXSM event analyses
Frequently asked questions about AXSM
Why did Axsome Therapeutics, Inc. (AXSM) stock move?
AXSM rose 3.8% to $220.89. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did AXSM stock rise?
AXSM gained 3.83% ($8.15) versus the prior close of $212.74, last trading at $220.89 on 1.7× average volume.
What is the analyst price target for AXSM?
The consensus analyst price target for AXSM is $269.35, about 21.9% above the current $220.89. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 0 downgrades.
How BestStocks tracks AXSM
This page is generated automatically by BestStocks' change-detection system after an earnings miss was detected and verified against independent data sources. It draws on 15 tracked change events for AXSM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 11, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.